Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

NCT00128531 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GP-Pharm